MM-718: Lisaftoclax (APG-2575) combined with novel therapeutic regimens in patients with relapsed or refractory (R/R) multiple myeloma (MM) or immunoglobulin light-chain (AL) amyloidosis
Home » MM-718: Lisaftoclax (APG-2575) combined with novel therapeutic regimens in patients with relapsed or refractory (R/R) multiple myeloma (MM) or immunoglobulin light-chain (AL) amyloidosis
2025
Ailawadhi S, Chanan-Khan A, Khouri J, Yannakou CK, Chen Z, Wang Y, Guo H, Wang H, Li M, Ahmad M, Yang D, Zhai Y. MM-718: Lisaftoclax (APG-2575) combined with novel therapeutic regimens in patients with relapsed or refractory (R/R) multiple myeloma (MM) or immunoglobulin light-chain (AL) amyloidosis. Clin Lymphoma Myeloma Leuk. vol. 25(suppl 1):, pp. S937. (2025 SOHO Poster)-S937. (2025 SOHO Poster), View